Position in ARGX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,040,880,612
+$393,278,878 QoQ
Shares Held
2,199,770
-2.5% QoQ
Ownership
3.54%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#4
of 504 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital World Investors holds $27,435,334,973 across 33 Biotechnology names. ARGX ranks #3 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
26,115,014 | $12,972,110,904 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
11,144,846 | $3,354,932,991 | |
| 3 | ARGX |
Argenx SE
This page
|
2,199,770 | $2,040,880,612 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
21,669,226 | $1,718,152,929 | |
| 5 | MRNA |
Moderna, Inc.
|
22,276,996 | $1,560,058,029 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,008,244 | $750,663,936 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
2,697,610 | $650,043,081 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
2,249,582 | $641,063,382 |
All Filings in ARGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,040,880,612 | 2,199,770 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,647,601,734 | 2,256,216 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,611,456,982 | 1,916,234 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,445,251,770 | 1,959,504 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,075,475,420 | 1,951,082 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,147,029,635 | 1,937,992 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,098,965,640 | 1,786,936 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $921,670,977 | 1,700,249 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $650,002,879 | 1,511,494 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $734,128,737 | 1,864,596 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $746,100,076 | 1,961,202 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $703,532,854 | 1,431,021 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $460,835,848 | 1,182,449 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $394,001,859 | 1,057,496 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $280,688,027 | 740,934 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $261,256,293 | 739,998 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $280,140,840 | 739,392 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $233,137,691 | 739,392 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $231,221,001 | 660,273 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $199,497,274 | 660,587 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $198,981,679 | 660,915 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $182,313,412 | 662,019 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $194,581,413 | 661,639 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $173,693,470 | 661,639 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $149,013,519 | 661,606 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $75,974,355 | 576,743 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||